A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected Individuals
- PMID: 26425694
- PMCID: PMC4563128
- DOI: 10.1016/j.ebiom.2015.06.019
A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected Individuals
Abstract
Background: Quantifying latently infected cells is critical to evaluate the efficacy of therapeutic strategies aimed at reducing the size of the long-lived viral reservoir, but the low frequency of these cells makes this very challenging.
Methods: We developed TILDA (Tat/rev Induced Limiting Dilution Assay) to measure the frequency of cells with inducible multiply-spliced HIV RNA, as these transcripts are usually absent in latently infected cells but induced upon viral reactivation. TILDA requires less than a million cells, does not require RNA extraction and can be completed in two days.
Findings: In suppressed individuals on ART, we found the median frequency of latently infected CD4 + T cells as estimated by TILDA to be 24 cells/million, which was 48 times more than the frequency measured by the quantitative viral outgrowth assay, and 6-27 times less than the frequencies of cells harbouring viral DNA measured by PCR-based assays. TILDA measurements strongly correlated with most HIV DNA assays. The size of the latent reservoir measured by TILDA was lower in subjects who initiated ART during the early compared to late stage of infection (p = 0.011). In untreated HIV disease, the frequency of CD4 + cells carrying latent but inducible HIV largely exceeded the frequency of actively producing cells, demonstrating that the majority of infected cells are transcriptionally silent even in the absence of ART.
Interpretations: Our results suggest that TILDA is a reproducible and sensitive approach to measure the frequency of productively and latently infected cells in clinical settings. We demonstrate that the latent reservoir represents a substantial fraction of all infected cells prior to ART initiation.
Research in context: In this manuscript, we describe the development of a novel assay that measures the magnitude of the latent HIV reservoir, the main barrier to HIV eradication. This novel assay, termed TILDA for Tat/rev Induced Limiting Dilution Assay, requires only 10 ml of blood, does not necessitate extraction of viral nucleic acids, is highly reproducible, covers a wide dynamic range of reservoir sizes and can be completed in two days. As such, TILDA may represent an alternative to existing assays used to evaluate the efficacy of therapeutic strategies aimed at reducing the size of the latent HIV reservoir.
Keywords: Eradication; HIV; Inducible virus; Latency; Multiply spliced RNA; Reservoir; TILDA.
Figures




Similar articles
-
TILDA: Tat/Rev Induced Limiting Dilution Assay.Methods Mol Biol. 2022;2407:365-372. doi: 10.1007/978-1-0716-1871-4_24. Methods Mol Biol. 2022. PMID: 34985676
-
Inter-Laboratory Reproducibility of Inducible HIV-1 Reservoir Quantification by TILDA.Viruses. 2020 Sep 2;12(9):973. doi: 10.3390/v12090973. Viruses. 2020. PMID: 32887284 Free PMC article.
-
Development of C-TILDA: A modified TILDA method for reservoir quantification in long term treated patients infected with subtype C HIV-1.J Virol Methods. 2020 Feb;276:113778. doi: 10.1016/j.jviromet.2019.113778. Epub 2019 Nov 19. J Virol Methods. 2020. PMID: 31756409
-
Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.Annu Rev Immunol. 2000;18:665-708. doi: 10.1146/annurev.immunol.18.1.665. Annu Rev Immunol. 2000. PMID: 10837072 Review.
-
Inducible HIV RNA transcription assays to measure HIV persistence: pros and cons of a compromise.Retrovirology. 2018 Jan 17;15(1):9. doi: 10.1186/s12977-017-0385-y. Retrovirology. 2018. PMID: 29343255 Free PMC article. Review.
Cited by
-
Current views on HIV-1 latency, persistence, and cure.Folia Microbiol (Praha). 2017 Jan;62(1):73-87. doi: 10.1007/s12223-016-0474-7. Epub 2016 Oct 5. Folia Microbiol (Praha). 2017. PMID: 27709447 Review.
-
The Latent Human Immunodeficiency Virus (HIV) Reservoir Resides Primarily in CD32-CD4+ T Cells in Perinatally HIV-Infected Adolescents With Long-Term Virologic Suppression.J Infect Dis. 2019 Jan 1;219(1):80-88. doi: 10.1093/infdis/jiy461. J Infect Dis. 2019. PMID: 30053296 Free PMC article.
-
Beyond the replication-competent HIV reservoir: transcription and translation-competent reservoirs.Retrovirology. 2018 Feb 2;15(1):18. doi: 10.1186/s12977-018-0392-7. Retrovirology. 2018. PMID: 29394935 Free PMC article. Review.
-
Follicular CD4 T Helper Cells As a Major HIV Reservoir Compartment: A Molecular Perspective.Front Immunol. 2018 Jun 18;9:895. doi: 10.3389/fimmu.2018.00895. eCollection 2018. Front Immunol. 2018. PMID: 29967602 Free PMC article. Review.
-
An Ultrasensitive p24 Assay to Measure HIV-1 in Diverse Biological Matrixes.Methods Mol Biol. 2024;2807:343-354. doi: 10.1007/978-1-0716-3862-0_23. Methods Mol Biol. 2024. PMID: 38743239
References
-
- Boulassel M.R., Chomont N., Pai N.P., Gilmore N., Sekaly R.P., Routy J.P. CD4 T cell nadir independently predicts the magnitude of the HIV reservoir after prolonged suppressive antiretroviral therapy. J. Clin. Virol. 2012;53(1):29–32. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials